1093.HK vs. BIDU

Last updated Jun 13, 2026

1093.HK (CSPC Pharmaceutical Group Ltd) and BIDU (Baidu, Inc.) are both stocks. 1093.HK operates in Drug Manufacturers - General (Healthcare), while BIDU operates in Internet Content & Information (Communication Services). Over the past 10 years, 1093.HK returned 17.71%/yr vs -3.14%/yr for BIDU. At a 0.16 correlation, their price movements are largely independent.

Performance

1093.HK vs. BIDU - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in CSPC Pharmaceutical Group Ltd (1093.HK) and Baidu, Inc. (BIDU). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

1093.HK is traded in HKD, while BIDU is traded in USD. To make them comparable, the BIDU values have been converted to HKD using the latest available exchange rates.

Returns By Period

In the year-to-date period, 1093.HK achieves a -14.12% return, which is significantly lower than BIDU's -10.81% return. Over the past 10 years, 1093.HK has outperformed BIDU with an annualized return of 17.71%, while BIDU has yielded a comparatively lower -3.14% annualized return.

1093.HK

• 1D: 0.42%
• 1M: -10.06%
• YTD: -14.12%
• 6M: -5.48%
• 1Y: -18.77%
• 3Y*: 6.09%
• 5Y*: -7.56%
• 10Y*: 17.71%

BIDU

• 1D: -0.30%
• 1M: -23.03%
• YTD: -10.81%
• 6M: -6.78%
• 1Y: 31.60%
• 3Y*: -6.70%
• 5Y*: -9.04%
• 10Y*: -3.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

1093.HK vs. BIDU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
1093.HK CSPC Pharmaceutical Group Ltd	-14.12%	81.38%	-30.97%	-7.80%	-0.70%	8.57%	61.50%	68.76%	-27.50%	94.71%
BIDU Baidu, Inc.	-10.81%	55.27%	-29.57%	4.11%	-23.00%	-30.82%	70.31%	-20.72%	-32.13%	43.55%

Correlation

The correlation between 1093.HK and BIDU is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jul 16, 2007	0.16

The correlation between 1093.HK and BIDU shifts across timeframes, from 0.11 (1 year) to 0.24 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

1093.HK vs. BIDU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

1093.HK

1093.HK Risk / Return Rank: 26
1093.HK Sharpe Ratio Rank: 26
1093.HK Sortino Ratio Rank: 26
1093.HK Omega Ratio Rank: 27
1093.HK Calmar Ratio Rank: 25
1093.HK Martin Ratio Rank: 25

BIDU

BIDU Risk / Return Rank: 62
BIDU Sharpe Ratio Rank: 64
BIDU Sortino Ratio Rank: 63
BIDU Omega Ratio Rank: 60
BIDU Calmar Ratio Rank: 63
BIDU Martin Ratio Rank: 62

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

1093.HK vs. BIDU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CSPC Pharmaceutical Group Ltd (1093.HK) and Baidu, Inc. (BIDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	1093.HK	BIDU	Difference
Sharpe ratio: Return per unit of total volatility	-0.38	0.63	-1.01
Sortino ratio: Return per unit of downside risk	-0.26	1.27	-1.53
Omega ratio: Gain probability vs. loss probability	0.97	1.15	-0.18
Calmar ratio: Return relative to maximum drawdown	-0.50	0.93	-1.43
Martin ratio: Return relative to average drawdown	-0.89	2.00	-2.90

1093.HK vs. BIDU - Sharpe Ratio Comparison

The current 1093.HK Sharpe Ratio is -0.38, which is lower than the BIDU Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of 1093.HK and BIDU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

1093.HK vs. BIDU - Drawdown Comparison

The maximum 1093.HK drawdown since its inception was -74.77%, roughly equal to the maximum BIDU drawdown of -77.34%. Use the drawdown chart below to compare losses from any high point for 1093.HK and BIDU.

Drawdown Indicators

	1093.HK	BIDU	Difference
Max Drawdown Largest peak-to-trough decline	-74.77%	-77.34%	+2.57%
Max Drawdown (1Y) Largest decline over 1 year	-38.44%	-34.08%	-4.36%
Max Drawdown (3Y) Largest decline over 3 years	-38.44%	-50.90%	+12.46%
Max Drawdown (5Y) Largest decline over 5 years	-60.67%	-62.96%	+2.29%
Max Drawdown (10Y) Largest decline over 10 years	-61.30%	-77.34%	+16.04%
Current Drawdown Current decline from peak	-35.97%	-65.58%	+29.61%
Average Drawdown Average peak-to-trough decline	-26.54%	-36.09%	+9.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.32%	15.82%	+5.50%

Volatility

1093.HK vs. BIDU - Volatility Comparison

The current volatility for CSPC Pharmaceutical Group Ltd (1093.HK) is 13.44%, while Baidu, Inc. (BIDU) has a volatility of 14.88%. This indicates that 1093.HK experiences smaller price fluctuations and is considered to be less risky than BIDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	1093.HK	BIDU	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.44%	14.88%	-1.44%
Volatility (6M) Calculated over the trailing 6-month period	35.31%	35.94%	-0.63%
Volatility (1Y) Calculated over the trailing 1-year period	50.52%	50.56%	-0.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.72%	51.83%	-7.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	47.08%	46.22%	+0.86%

Dividends

1093.HK vs. BIDU - Dividend Comparison

1093.HK's dividend yield for the trailing twelve months is around 1.93%, while BIDU has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
1093.HK CSPC Pharmaceutical Group Ltd	1.93%	2.85%	6.28%	3.44%	2.44%	2.01%	1.79%	1.86%	2.55%	1.46%	2.55%	2.43%
BIDU Baidu, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both 1093.HK and BIDU in my portfolio?

1093.HK and BIDU have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.